Sharps technology signs 5-year, $200 million syringe sales agreement and amendment to asset purchase agreement to begin producing prefillable specialty copolymer syringes in the u.s.

Sharps will strengthen its manufacturing capacity with a $35 million acquisition of assets, establishing the company's position in the specialized copolymer prefillable syringe (pfs) system industry in the u.s.
STSS Ratings Summary
STSS Quant Ranking